NuScale Stock Falls 14% as UBS Sees a $95 Million EBITDA Gap
NuScale Power Corp. (SMR) shares dropped 13.66% after UBS downgraded it to Sell, cutting its price target to $6 from $10. Analyst Jon Windham cited extended build timelines and lack of firm customer commitments, estimating a $95 million EBITDA gap by 2028. UBS projects negative earnings throughout the forecast period, with revenue growing from $185 million in 2028 to $924 million in 2030.
How this was made
The 30-second read
Why it matters
The downgrade reflects heightened execution risk and could trigger further sell‑offs in the nuclear SMR space.
Market read
Analyst downgrade with a sharp target cut drives immediate price decline and may affect related clean‑energy equities.
What to watch
Upcoming government incentives for small modular reactors could mitigate timeline concerns.
Background
UBS analyst Jon Windham highlighted an extended build timeline, lack of firm customer commitments, and a large EBITDA forecast gap.
Ticker impact
UBS downgraded NuScale Power to Sell and cut the price target to $6, triggering a 13.66% intraday drop.
Further downside pressure if no new positive catalyst emerges.
Analyst downgrade with a substantial target reduction and explicit EBITDA gap creates immediate sell pressure.
Market effects
Potentially drags other small‑cap nuclear and clean‑energy stocks as investors reassess project timelines.
Limited to U.S. small‑cap market; no broader regional effect.
Minimal global impact beyond niche nuclear sector.
Counterpoint
If NuScale secures a firm contract soon, the downgrade may be premature and the stock could rebound.
Key entities
- companyNuScale Power Corp.
U.S. listed nuclear small modular reactor developer.
- analyst_firmUBS
Investment bank that issued the downgrade.
